170 related articles for article (PubMed ID: 30388878)
1. Antiproliferative Activity and Molecular Docking of Novel Double-Modified Colchicine Derivatives.
Majcher U; Klejborowska G; Moshari M; Maj E; Wietrzyk J; Bartl F; Tuszynski JA; Huczyński A
Cells; 2018 Nov; 7(11):. PubMed ID: 30388878
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents.
Majcher U; Klejborowska G; Kaik M; Maj E; Wietrzyk J; Moshari M; Preto J; Tuszynski JA; Huczyński A
Cells; 2018 Nov; 7(11):. PubMed ID: 30463236
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, anticancer activity and molecular docking studies of N-deacetylthiocolchicine and 4-iodo-N-deacetylthiocolchicine derivatives.
Klejborowska G; Urbaniak A; Maj E; Wietrzyk J; Moshari M; Preto J; Tuszynski JA; Chambers TC; Huczyński A
Bioorg Med Chem; 2021 Feb; 32():116014. PubMed ID: 33465696
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes.
Majcher U; Urbaniak A; Maj E; Moshari M; Delgado M; Wietrzyk J; Bartl F; Chambers TC; Tuszynski JA; Huczyński A
Bioorg Chem; 2018 Dec; 81():553-566. PubMed ID: 30248507
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antiproliferative activity and molecular docking of Colchicine derivatives.
Huczyński A; Majcher U; Maj E; Wietrzyk J; Janczak J; Moshari M; Tuszynski JA; Bartl F
Bioorg Chem; 2016 Feb; 64():103-12. PubMed ID: 26794327
[TBL] [Abstract][Full Text] [Related]
6. New Series of Double-Modified Colchicine Derivatives: Synthesis, Cytotoxic Effect and Molecular Docking.
Krzywik J; Aminpour M; Maj E; Mozga W; Wietrzyk J; Tuszyński JA; Huczyński A
Molecules; 2020 Aug; 25(15):. PubMed ID: 32748887
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation and molecular docking studies of new amides of 4-bromothiocolchicine as anticancer agents.
Klejborowska G; Urbaniak A; Preto J; Maj E; Moshari M; Wietrzyk J; Tuszynski JA; Chambers TC; Huczyński A
Bioorg Med Chem; 2019 Dec; 27(23):115144. PubMed ID: 31653441
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antiproliferative activity, and molecular docking studies of 4-chlorothiocolchicine analogues.
Klejborowska G; Moshari M; Maj E; Majcher U; Preto J; Wietrzyk J; Tuszynski JA; Huczyński A
Chem Biol Drug Des; 2020 Jan; 95(1):182-191. PubMed ID: 31483093
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Antiproliferative Activity and Molecular Docking Studies of Novel Doubly Modified Colchicine Amides and Sulfonamides as Anticancer Agents.
Krzywik J; Mozga W; Aminpour M; Janczak J; Maj E; Wietrzyk J; Tuszyński JA; Huczyński A
Molecules; 2020 Apr; 25(8):. PubMed ID: 32295119
[TBL] [Abstract][Full Text] [Related]
10.
Pallante L; Rocca A; Klejborowska G; Huczynski A; Grasso G; Tuszynski JA; Deriu MA
Front Chem; 2020; 8():108. PubMed ID: 32154219
[TBL] [Abstract][Full Text] [Related]
11. Interactions of long-chain homologues of colchicine with tubulin.
Marzo-Mas A; Barbier P; Breuzard G; Allegro D; Falomir E; Murga J; Carda M; Peyrot V; Marco JA
Eur J Med Chem; 2017 Jan; 126():526-535. PubMed ID: 27915168
[TBL] [Abstract][Full Text] [Related]
12. Effects on tubulin polymerization and down-regulation of c-Myc, hTERT and VEGF genes by colchicine haloacetyl and haloaroyl derivatives.
Marzo-Mas A; Falomir E; Murga J; Carda M; Marco JA
Eur J Med Chem; 2018 Apr; 150():591-600. PubMed ID: 29550732
[TBL] [Abstract][Full Text] [Related]
13. Computational design and biological testing of highly cytotoxic colchicine ring A modifications.
Torin Huzil J; Winter P; Johnson L; Weis AL; Bakos T; Banerjee A; Luduena RF; Damaraju S; Tuszynski JA
Chem Biol Drug Des; 2010 Jun; 75(6):541-50. PubMed ID: 20408852
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors.
Wang YT; Cai XC; Shi TQ; Zhang YL; Wang ZC; Liu CH; Zhu HL
Chem Biol Drug Des; 2017 Jul; 90(1):112-118. PubMed ID: 28032450
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
Alswah M; Bayoumi AH; Elgamal K; Elmorsy A; Ihmaid S; Ahmed HEA
Molecules; 2017 Dec; 23(1):. PubMed ID: 29280968
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antiproliferative and antibacterial evaluation of C-ring modified colchicine analogues.
Huczyński A; Rutkowski J; Popiel K; Maj E; Wietrzyk J; Stefańska J; Majcher U; Bartl F
Eur J Med Chem; 2015 Jan; 90():296-301. PubMed ID: 25437616
[TBL] [Abstract][Full Text] [Related]
17. Design and biological evaluation of novel tubulin inhibitors as antimitotic agents using a pharmacophore binding model with tubulin.
Kim DY; Kim KH; Kim ND; Lee KY; Han CK; Yoon JH; Moon SK; Lee SS; Seong BL
J Med Chem; 2006 Sep; 49(19):5664-70. PubMed ID: 16970393
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and molecular docking of novel diarylcyclohexenone and diarylindazole derivatives as tubulin polymerization inhibitors.
Ahmed RI; Osman EE; Awadallah FM; El-Moghazy SM
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):176-188. PubMed ID: 27771966
[TBL] [Abstract][Full Text] [Related]
19. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
